Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
fentaNYL
fentaNYL
Brand names: Duragesic, FentaNYL Citrate, Fentora
| Form | Strength |
|---|---|
| FILM, EXTENDED RELEASE, TRANSDERMAL | 12 mcg/hr; 25 mcg/hr; 50 mcg/hr; 75 mcg/hr; 100 mcg/hr |
| LOZENGE, ORAL TRANSMUCOSAL | 200 mcg; 400 mcg; 600 mcg; 800 mcg; 1200 mcg; 1600 mcg |
| SOLUTION, INJECTABLE | 10 mcg/mL-0.9%; 50 mcg/mL |
| TABLET, BUCCAL | 200 mcg |
Last updated: Nov. 30, 2021
- RCRA: Disposal
- RCRA: Management of Pharmaceutical Waste Policy
- Do Not Crush: Lozenge/Buccal Tablet
- Black Box Warning: Use in chronic pain only
- REMS: Fentanyl -Transmucosal Immediate Release; Opioid Analgsic REMS
Class II
Fentanyl patch for chronic pain only - do NOT use in opioid naïve patients (FDA).
Fentanyl may be given via hypodermoclysis (HDC/subcutaneous infusion). See Procedure 904.4991
Legacy Guidelines:
Use in mechanically ventilated patients, See the Pain, Agitation and Delirium Protocol (aka "PAD") Protocol 901.6008
For pediatric long term sedation weaning: See Protocol 912.6016
Infusion Concentrations and Ranges:
Adult General Titration Ranges and Administration (weight based dosing): See Handout (updated Aug 2016)